identified in vivo in spleen, verifying LTC as a physiologically relevant culture system for production of this novel DC subset [11] .
The in vivo subset has been tentatively named L-DC.
Spleen LTC are unique in vitro culture systems that support development of both progenitors and progeny myeloid DC-like cells within the same culture [7, 12] . They can be maintained continuously over many years [13, 14] , implicating a progenitor or stem cell with self-renewing properties. We have also derived a splenic endothelial cell line, STX3 from one LTC, and have characterized it as an immature, endothelial-like cell line [15, 16] which supports continuous haematopoiesis from overlaid BM or spleen cells [17] . To date, we have characterized stroma as endothelial cells on the basis of gene and marker expression and ability to form tube-like structures in Matrigel [15, 16, 18] . They also produce high levels of CXCL12, a factor that recruits HSC into BM niches [19, 20] . 
In line with the restricted in vitro development of only L-DC in spleen stromal cocultures, we questioned whether HSC developing in different sites are perhaps subject to different niche signals, and distinct in terms of their haematopoietic potential. We compared spleen and BM for their ability to reconstitute mice and to give rise to all haematopoietic cell lineages including DC. In particular, we tested whether spleen HSC and BM HSC have equal reconstitution potential for antigen presenting cells, and particularly for the L-DC subset.

Materials and methods
Animals
Preparation of irradiation chimeras
Results
In order to compare the capacity of HSC in neonatal spleen versus adult BM for capacity to produce L-DC, adoptive transfer of neonatal splenocytes was followed by flow cytometric analysis to delineate APC subsets in spleens of chimeras established across 8 to 51 weeks. Reconstitution of other cell lineages including T cells, B cells and monocytes/macrophages was also assessed in chimeras established for Ͼ17 weeks to determine long-term (LT) multi-lineage cell reconstitution potential reflective of LT-HSC. The seeding of HSC into BM niches in host mice was also determined by assessing the frequency of host-and donortype cells expressing the ckit marker.
Investigating the in vivo differentiative capacity of spleen-derived HSC for L-DC
0). For SPL chimeras, this calculation will determine whether reconstitution
Fig. 2 Dendritic cell reconstitution by neonatal spleen HSC. Spleen (SPL) and bone marrow (BM) chimeras were prepared as described in Figure 1. For analysis of long-term (Ͼ25 week) reconstitution, spleens were collected, enriched for DC by depletion of T and B cells, and stained with antibodies specific for CD45.1, CD11c, CD11b, CD8 and MHC-II. Prior to flow cytometry, cells were incubated with propidium iodide (PI; 1 g/ml) for gating of live (PI
Ϫ ) cells. C57BL/6J splenocytes were stained as a CD45.1 Ϫ control. (A) Individual spleen APC subsets (L-DC, myeloid cells, CD8
Ϫ cDC and CD8 ϩ cDC) were gated as shown in Figure 1A and assessed for donor-cell (CD45.1 ϩ
) composition. Numbers in gates indicate per cent positive cells. Labelled chimeras (*) indicate mice showing only partial donor reconstitution with some evidence of host-type cell development. (B) The relative prevalence of donor-to host-type cells was calculated for each spleen APC subset in animals showing partial donor reconstitution as indicated in Figures 1 and 2 (*). The fold-increase of donor-to host-type cells was calculated relative to CD8
Ϫ cDC assigned a fold-increase of 1 [21] . A more differentiated common dendritic cell progenitor (CDP) has also been identified in BM which gives rise to only cDC [22] . However, both these progenitors are specific to BM and are not found in spleen [23] . Spleen has however been shown to contain pre-cDC [24] and precursors of CD8 ϩ cDC [25] [27] , and their function in relation to osteoblastic niches, which exist only in BM [28, 29] .
